The invention belongs to the field of medical chemistry, and discloses an amorphous crystallization form of a ceritinib compound and a pharmaceutical composition of the ceritinib compound. The amorphous crystallization form of the compound has the characteristic of being high in stability, and the medicinal requirements are met. According to the invention, the preparation technology is stable, the reproducibility is good, and the requirements of industrial mass production are met.